Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AMIXAutonomix Medical, Inc.

Nasdaq · CIK 0001617867
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end0331
XBRL facts170

Identity from submissions API

NameAutonomix Medical, Inc.
CIK0001617867
TickersAMIX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN471607810
LEI—
Fiscal year end0331
State of incorporationDE DE
Phone832-277-7816
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
21 WATERWAY AVENUE, SUITE 300
THE WOODLANDS
TX
77380
TX
Mailing address
21 WATERWAY AVENUE, SUITE 300
THE WOODLANDS
TX
77380
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

151 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 8-K FORM 8-K 7.01,9.01 0001437749-26-037802 001-41940 261576692 34 4235009 1 1
2026-11-10 10-Q FORM 10-Q 0001437749-26-036033 001-41940 261538588 34 5758187 1 1
2026-11-03 8-K FORM 8-K 5.02,5.07,9.01 0001437749-26-034696 001-41940 261518846 34 308468 1 1
2026-10-13 3 FORM 3 0001437749-26-032544 9304
2026-09-21 4 FORM 4 - SMITH, TRENT 0001437749-26-030774 4553
2026-09-16 424B3 FORM 424B3 0001437749-26-030570 333-298774 261384484 33 115505
2026-09-16 8-K FORM 8-K 5.02,9.01 0001437749-26-030505 001-41940 261382437 34 223529 1 1
2026-09-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002973 333-298774 261382287 33 1776
2026-09-14 DEFA14A FORM DEFA14A 0001437749-26-030350 001-41940 261378226 34 425177
2026-09-14 DEF 14A FORM DEF 14A 0001437749-26-030345 001-41940 261378147 34 956760 1 1
2026-09-11 424B5 FORM 424B5 0001437749-26-030188 333-285464 261375089 33 478296 1 1
2026-09-08 4 FORM 4 - KLEMP, WALLY 0001437749-26-029835 4499
2026-09-08 4 FORM 4 - BISSON, LORI 0001437749-26-029833 4503
2026-09-08 4 FORM 4 - HAUSER, BRAD 0001437749-26-029830 4625
2026-09-04 PRE 14A FORM PRE 14A 0001437749-26-029716 001-41940 261362797 34 949208 1 1
2026-09-04 S-3 FORM S-3 0001437749-26-029712 333-298774 261362738 33 527809 1 1
2026-08-26 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-26-029024 001-41940 261323877 34 545706 1 1
2026-08-13 10-Q FORM 10-Q 0001437749-26-027429 001-41940 261269400 34 4716749 1 1
2026-08-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002539 333-297760 261241083 33 1776
2026-07-31 424B5 FORM 424B5 0001437749-26-025250 333-285464 261229362 33 331211
2026-07-28 S-3 FORM S-3 0001437749-26-024697 333-297760 261212821 33 535120 1 1
2026-07-28 8-K FORM 8-K 8.01 0001437749-26-024597 001-41940 261208977 34 164389 1 1
2026-07-15 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-26-023638 001-41940 261177992 34 527511 1 1
2026-07-10 8-K FORM 8-K 8.01 0001437749-26-023248 001-41940 261167029 34 167581 1 1
2026-06-24 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001437749-26-021495 001-41940 261112967 34 554025 1 1
2026-06-15 10-K/A FORM 10-K/A 0001437749-26-020686 001-41940 261092080 34 580894 1 1
2026-05-27 10-K FORM 10-K 0001437749-26-018573 001-41940 261026672 34 6707114 1 1
2026-04-02 S-8 FORM S-8 0001437749-26-011167 333-294858 26835069 33 378400 1 1
2026-02-11 10-Q FORM 10-Q 0001437749-26-003816 001-41940 26621778 34 4925371 1 1
2026-01-16 8-K FORM 8-K 3.01 0001437749-26-001381 001-41940 26537646 34 169078 1 1
2026-01-09 8-K FORM 8-K 7.01,9.01 0001437749-26-000937 001-41940 26521475 34 2042620 1 1
2025-12-12 424B3 FORM 424B3 0001437749-25-037748 333-291825 251568970 33 109015
2025-12-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003678 333-291825 251566443 33 1776
2025-12-09 CORRESP filename1.htm 0001437749-25-037269 8570
2025-11-26 S-3 FORM S-3 0001437749-25-036460 333-291825 251531247 33 527936 1 1
2025-11-19 8-K FORM 8-K 1.01,3.02,9.01 0001437749-25-035733 001-41940 251499546 34 820134 1 1
2025-11-12 10-Q FORM 10-Q 0001437749-25-034517 001-41940 251474257 34 5506238 1 1
2025-11-03 8-K FORM 8-K 5.07,9.01 0001437749-25-032798 001-41940 251445033 34 301842 1 1
2025-10-06 424B3 FORM 424B3 0001437749-25-030544 333-290472 251377486 33 13281878 1 1
2025-09-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003248 333-290472 251362350 33 1776
2025-09-29 CORRESP filename1.htm 0001437749-25-030047 6965
2025-09-29 UPLOAD filename1.pdf 0000000000-25-010575 333-290472 40252
2025-09-23 S-1 FORM S-1 0001437749-25-029750 333-290472 251334540 33 13458208 1 1
2025-09-12 DEFA14A FORM DEFA14A 0001437749-25-028962 001-41940 251312282 34 48440
2025-09-12 DEF 14A FORM DEF 14A 0001437749-25-028954 001-41940 251312063 34 1403301 1 1
2025-09-11 424B3 FORM 424B3 0001437749-25-028860 333-289741 251309206 33 13083998 1 1
2025-09-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002872 333-289741 251301567 33 1776
2025-09-04 CORRESP filename1.htm 0001437749-25-028388 10683
2025-09-03 S-1/A FORM S-1/A 0001437749-25-028296 333-289741 251290759 33 197139
2025-08-29 PRE 14A FORM PRE 14A 0001437749-25-028052 001-41940 251281887 34 1508615
2025-08-28 UPLOAD filename1.pdf 0000000000-25-009241 333-289741 40217
2025-08-27 8-K FORM 8-K 8.01,9.01 0001437749-25-027890 001-41940 251266432 34 199589 1 1
2025-08-26 8-K FORM 8-K 1.01,3.02,9.01 0001437749-25-027719 001-41940 251252569 34 636704 1 1
2025-08-25 424B5 FORM 424B5 0001437749-25-027697 333-285464 251252029 33 332327
2025-08-20 S-1 FORM S-1 0001437749-25-027461 333-289741 251237588 33 13197950 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021893 005-94449 251220178 34 12341
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003629 005-94449 251218827 34 16680
2025-08-13 4 FORM 4 - HAUSER, BRAD 0001437749-25-026641 5404
2025-08-13 4 FORM 4 - CAPELLI, CHRIS 0001437749-25-026640 5285
2025-08-13 4 FORM 4 - KLEMP, WALLY 0001437749-25-026638 5441
2025-08-13 4 FORM 4 - BISSON, LORI 0001437749-25-026637 7536
2025-08-13 4 FORM 4 - SMITH, TRENT 0001437749-25-026636 7581
2025-08-13 10-Q FORM 10-Q 0001437749-25-026564 001-41940 251212667 34 5318604 1 1
2025-07-28 10-K/A FORM 10-K/A 0001437749-25-023669 001-41940 251156297 34 679406 1 1
2025-07-23 424B3 FORM 424B3 0001437749-25-023272 333-282940 251141455 33 58140
2025-07-22 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-25-023246 001-41940 251140897 34 446714 1 1
2025-07-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002226 333-282940 251120033 33 1789
2025-07-03 POS AM POS AM 0001437749-25-022165 333-282940 251106240 33 8919181 1 1
2025-05-29 10-K FORM 10-K 0001437749-25-018831 001-41940 251004464 34 9040599 1 1
2025-04-30 8-K FORM 8-K 7.01,9.01 0001437749-25-013631 001-41940 25891135 34 2530012 1 1
2025-03-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000644 333-285464 25729813 33 1782
2025-03-10 CORRESP filename1.htm 0001437749-25-006791 7576
2025-03-07 S-3/A FORM S-3/A 0001437749-25-006700 333-285464 25721351 33 137729
2025-03-07 UPLOAD filename1.pdf 0000000000-25-002555 333-285464 40188
2025-02-28 S-3 FORM S-3 0001437749-25-005747 333-285464 25692032 33 1713006
2025-02-28 8-K FORM 8-K 1.01,8.01,9.01 0001437749-25-005739 001-41940 25691336 34 1247641 1 1
2025-02-13 8-K FORM 8-K 2.02,9.01 0001437749-25-003673 001-41940 25617252 34 206997 1 1
2025-02-13 10-Q FORM 10-Q 0001437749-25-003669 001-41940 25617240 34 6688516 1 1
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000034 005-94449 25601767 34 12317
2025-01-22 8-K FORM 8-K 7.01,9.01 0001437749-25-001558 001-41940 25545920 34 1969513 1 1
2024-12-03 SC 13G AUTONOMIX MEDICAL, INC. 0000902664-24-006824 005-94449 241524092 34 147937
2024-11-27 SC 13G SC 13G 0001104659-24-123484 005-94449 241507512 34 66938
2024-11-25 8-K FORM 8-K 1.01,8.01,9.01 0001437749-24-036182 001-41940 241497023 34 1156280 1 1
2024-11-25 424B4 FORM 424B4 0001437749-24-036090 333-282940 241491874 33 2870185
2024-11-22 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-11-22 09:00:00 9999999995-24-003556 333-282940 241491738 33 1783
2024-11-19 CORRESP filename1.htm 0001437749-24-035779 9444
2024-11-19 CORRESP filename1.htm 0001437749-24-035778 6539
2024-11-12 S-1/A FORM S-1/A 0001437749-24-034531 333-282940 241447837 33 2983152
2024-11-12 8-K FORM 8-K 2.02,9.01 0001437749-24-034326 001-41940 241443499 34 205297 1 1
2024-11-08 10-Q FORM 10-Q 0001437749-24-034230 001-41940 241441601 34 5502252 1 1
2024-11-04 8-K FORM 8-K 8.01 0001437749-24-033163 001-41940 241424636 34 170892 1 1
2024-11-01 S-1 FORM S-1 0001437749-24-032896 333-282940 241417240 33 3693270
2024-10-28 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001437749-24-032175 001-41940 241398278 34 975380 1 1
2024-10-17 8-K FORM 8-K 5.07 0001437749-24-031491 001-41940 241378393 34 187261 1 1
2024-10-07 SC 13G FORM SC 13G 0001104659-24-106486 005-94449 241356242 34 43973
2024-09-20 8-K FORM 8-K 3.01 0001437749-24-029752 001-41940 241313609 34 170961 1 1
2024-09-05 DEFA14A FORM DEFA14A 0001437749-24-028441 001-41940 241279006 34 32922
2024-09-04 DEF 14A FORM DEF 14A 0001437749-24-028431 001-41940 241278788 34 776418
2024-08-23 PRE 14A FORM PRE 14A 0001437749-24-027680 001-41940 241237072 34 814570
2024-08-13 10-Q FORM 10-Q 0001437749-24-026451 001-41940 241202691 34 4788724 1 1
2024-08-13 8-K FORM 8-K 2.02,9.01 0001437749-24-026162 001-41940 241198878 34 203607 1 1
2024-08-02 UPLOAD filename1.pdf 0000000000-24-008851 377-07354 40416
2024-07-26 10-K/A FORM 10-K/A 0001437749-24-023626 001-41940 241148049 34 600421 1 1
2024-07-26 4 FORM 4 - ROBINS D. 0001437749-24-023598 5621
2024-07-26 DRS filename1.htm 0001437749-24-023491 377-07354 241143032 33 2145570
2024-07-15 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001437749-24-022711 001-41940 241115904 34 318476 1 1
2024-06-24 4 FORM 4 0001437749-24-021106 5230
2024-06-24 4 FORM 4 0001437749-24-021105 5221
2024-06-24 4 FORM 4 0001437749-24-021104 5229
2024-06-21 8-K FORM 8-K 5.02 0001437749-24-021003 001-41940 241061431 34 169636 1 1
2024-06-20 4 FORM 4 0001437749-24-020871 5350
2024-06-20 3 FORM 3 0001437749-24-020870 9211
2024-06-20 4 OWNERSHIP DOCUMENT 0001104659-24-073596 6342
2024-06-18 8-K FORM 8-K 7.01,9.01 0001437749-24-020591 001-41940 241050232 34 3662430 1 1
2024-06-17 8-K FORM 8-K 3.02,5.02,7.01,9.01 0001437749-24-020534 001-41940 241049250 34 387377 1 1
2024-05-31 S-8 FORM S-8 0001437749-24-018937 333-279894 241011036 33 288462
2024-05-31 10-K FORM 10-K 0001437749-24-018932 001-41940 241010591 34 7537827 1 1
2024-05-31 8-K FORM 8-K 2.02,9.01 0001437749-24-018924 001-41940 241010467 34 210388 1 1
2024-03-04 8-K FORM 8-K 7.01,9.01 0001683168-24-001265 001-41940 24713012 34 1416747 1 1
2024-02-26 SC 13D SCHEDULE 13D 0001683168-24-001176 005-94449 24679748 34 43838
2024-02-15 SC 13D SC 13D 0001683168-24-001033 005-94449 24644834 34 43811
2024-02-13 10-Q QUARTERLY REPORT 0001683168-24-000918 001-41940 24626571 34 3666542 1 1
2024-02-01 3 PRIMARY DOCUMENT 0001577164-24-000001 3819
2024-01-31 8-K CURRENT REPORT 3.02,7.01,8.01,9.01 0001683168-24-000570 001-41940 24580815 34 245504 1 1
2024-01-26 3 xslF345X02/ownership.xml 0001683168-24-000517 5792
2024-01-26 3 xslF345X02/ownership.xml 0001683168-24-000516 10472
2024-01-26 3 xslF345X02/ownership.xml 0001683168-24-000515 9689
2024-01-26 3 xslF345X02/ownership.xml 0001683168-24-000514 9792
2024-01-26 3 xslF345X02/ownership.xml 0001683168-24-000513 9596
2024-01-26 3 xslF345X02/ownership.xml 0001683168-24-000512 10883
2024-01-26 CERT AMIX_8A_Cert.pdf 0001354457-24-000039 001-41940 24568800 34 214254
2024-01-26 8-A12B FORM 8-A 0001683168-24-000462 001-41940 24564661 34 14629
2024-01-26 253G2 253G2 0001683168-24-000455 024-12296 24564319 33 1905857
2024-01-25 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-24-000006 024-12296 24563973 33 1784
2024-01-19 1-A POS xsl1-A_X01/primary_doc.xml 0001683168-24-000350 024-12296 24545448 33 2217113
2024-01-11 253G2 OFFERING CIRCULAR 0001683168-24-000209 024-12296 24527998 33 1905838
2024-01-09 1-SA 1-SA 0001683168-24-000153 24R-00922 24524038 33 255571
2023-10-16 253G2 OFFERING CIRCULAR 0001683168-23-007193 024-12296 231327893 33 1659665
2023-09-29 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-23-000334 024-12296 231297478 33 1709
2023-09-29 1-A/A xsl1-A_X01/primary_doc.xml 0001683168-23-006840 024-12296 231296356 33 1720937
2023-09-15 CORRESP filename1.htm 0001683168-23-006486 24495
2023-09-15 1-A/A xsl1-A_X01/primary_doc.xml 0001683168-23-006484 024-12296 231259236 33 2646602
2023-09-06 UPLOAD filename1.pdf 0000000000-23-009860 50250
2023-08-22 1-A/A xsl1-A_X01/primary_doc.xml 0001683168-23-005969 024-12296 231190673 33 2388622
2023-08-21 CORRESP filename1.htm 0001683168-23-005971 51697
2023-08-03 UPLOAD filename1.pdf 0000000000-23-008378 69380
2023-07-07 1-A xsl1-A_X01/primary_doc.xml 0001683168-23-004711 024-12296 231074680 33 1441817
2023-06-01 D xslFormDX01/primary_doc.xml 06b 0001617867-23-000005 021-483110 23984074 33 8802
2023-03-20 D xslFormDX01/primary_doc.xml 06b 0001617867-23-000003 021-476335 23746102 33 8793
2022-04-06 D xslFormDX01/primary_doc.xml 06b 0001683168-22-002404 021-440665 22810336 33 9207
2014-09-03 D xslFormDX01/primary_doc.xml 06b 0001617867-14-000001 021-224019 141080148 33 8095

Latest XBRL company facts

One latest value per concept from companyfacts (170 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.05M 2026-11-06 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
dei EntityPublicFloat Entity Public Float USD 6.31M 2025-09-30 2025 FY 10-K/A 2026-06-15 0001437749-26-020686
ffd NetFeeAmt NetFeeAmt USD 803.74 2026-08-31 S-3 2026-09-04 0001437749-26-029712
ffd TtlFeeAmt TtlFeeAmt USD 803.74 2026-08-31 S-3 2026-09-04 0001437749-26-029712
ffd TtlOfferingAmt TtlOfferingAmt USD 5.82M 2026-08-31 S-3 2026-09-04 0001437749-26-029712
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-31 S-3 2026-09-04 0001437749-26-029712
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-31 S-3 2026-09-04 0001437749-26-029712
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 630,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 624,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 65,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 100,000 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 79.89M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 17,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 346,000 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 53,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 7,000 2026-04-01 2026-06-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 4.51M 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-02-11 0001437749-26-003816
us-gaap AdvertisingExpense Advertising Expense USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.29M 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap Assets Assets USD 8.20M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AssetsCurrent Assets, Current USD 8.18M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap AssetsNoncurrent Assets, Noncurrent USD 19,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap Cash Cash USD 1.22M 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.69M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.22M 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 7.69M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 353,000 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 688,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.02 2023-12-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1,194 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.96M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.96M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 670 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0001437749-24-018932
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 36,000 2025-04-01 2025-12-31 2026 Q3 10-Q 2026-02-11 0001437749-26-003816
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 110,000 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 7.92M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 1.97M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.68M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 7.92M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 7,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -6.52 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.74 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.131 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.004 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 8,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.001 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.003 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 800,000 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0001437749-24-018932
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 334,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 4.60M 2024-12-31 2025 Q3 10-Q 2025-02-13 0001437749-25-003669
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0001437749-24-018932
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.85M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -5.85M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.19M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -3.51M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 5,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -44,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -53,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 490,000 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -153,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -380,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -168,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap InterestAndOtherIncome Interest and Other Income USD 47,000 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap InterestExpense Interest Expense USD 33,000 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap InterestExpenseDebt Interest Expense, Debt USD 100,000 2024-04-01 2024-12-31 2025 Q3 10-Q 2025-02-13 0001437749-25-003669
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 93,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap Liabilities Liabilities USD 1.25M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.20M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.25M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 0 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap LongTermDebt Long-term Debt USD 1.46M 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 1.20M 2024-12-31 2025 Q3 10-Q 2025-02-13 0001437749-25-003669
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 6.85M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -6.16M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -5.85M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 93,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap OperatingExpenses Operating Expenses USD 5.95M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -5.95M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 9.40M 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 64,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap OtherAssetsCurrent Other Assets, Current USD 484,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 4.97M 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 222,000 2026-06-30 2027 Q1 10-Q 2026-08-13 0001437749-26-027429
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 1.10M 2024-04-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 25,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 17,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 7,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap PrepaidInsurance Prepaid Insurance USD 143,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2025-01-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2025-01-01 2025-03-31 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-08-13 0001437749-26-027429
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.00M 2025-04-01 2025-12-31 2026 Q3 10-Q 2026-02-11 0001437749-26-003816
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 7.50M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 100,000 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 19,000 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 3.10M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -72.95M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap Revenues Revenues USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 55,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 3.70M 2025-07-01 2025-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 10,047 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 532,060 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 292 2024-12-31 2025 Q3 10-Q 2025-02-13 0001437749-25-003669
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 76 2024-12-31 2025 Q3 10-Q 2025-02-13 0001437749-25-003669
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 1.29M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-13 0001437749-25-026564
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 48 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 1.93M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 1.15M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.00M 2024-03-31 2024 FY 10-K 2024-05-31 0001437749-24-018932
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 149 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 40.63 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-13 0001437749-25-026564
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 0 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 48 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 1.70M 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 597 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) shares 942,305 2024-04-01 2024 Q1 10-Q 2024-08-13 0001437749-24-026451
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 40.63 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-13 0001437749-25-026564
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-13 0001437749-25-026564
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 840 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.85 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap SharePrice Share Price USD/shares 100 2024-01-26 2025 FY 10-K 2025-05-29 0001437749-25-018831
us-gaap ShortTermBorrowings Short-term Debt USD 1.13M 2024-12-31 2025 Q3 10-Q 2025-02-13 0001437749-25-003669
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 6.94M 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 21 2026-06-24 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap StockIssued1 Stock Issued USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 12,945 2024-10-24 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-13 0001437749-25-026564
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.18M 2024-04-01 2025-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 473,000 2025-07-01 2025-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 0 2023-10-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.20M 2025-04-01 2026-03-31 2026 FY 10-K 2026-05-27 0001437749-26-018573
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 13.49M 2023-04-01 2023-12-31 2024 Q3 10-Q 2024-02-13 0001683168-24-000918
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 897,447 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-10 0001437749-26-036033

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →